- Earn 4.5% interest on uninvested cash with Gold
- Get up to $50,000 in instant deposits with Gold
- Easy, user-friendly trading
- Unlimited bonus amounts Oct 16-27
Ayala Pharmaceuticals Inc is a business based in the US. Ayala Pharmaceuticals Inc shares (AYLA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.00 – the same closing value as a week prior. Ayala Pharmaceuticals Inc employs 35 staff and has a trailing 12-month revenue of around $1.7 million.
Our top picks for where to buy Ayala Pharmaceuticals Inc stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Ayala Pharmaceuticals Inc stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – AYLA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Ayala Pharmaceuticals Inc stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Ayala Pharmaceuticals Inc stock price (NASDAQ: AYLA)
Use our graph to track the performance of AYLA stocks over time.Ayala Pharmaceuticals Inc shares at a glance
Latest market close | $0.00 |
---|---|
52-week range | $0.00 - $0.00 |
50-day moving average | $0.51 |
200-day moving average | $1.17 |
Wall St. target price | $12.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-2.71 |
Is it a good time to buy Ayala Pharmaceuticals Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Ayala Pharmaceuticals Inc price performance over time
Historical closes compared with the close of $0 from 2023-02-02
1 week (2024-10-06) | N/A |
---|---|
1 month (2024-09-13) | N/A |
3 months (2024-07-13) | N/A |
6 months (2024-04-13) | N/A |
1 year (2023-10-13) | N/A |
---|---|
2 years (2022-10-17) | -100.00% |
3 years (2021-10-15) | -100.00% |
5 years (2019-10-13) | N/A |
Ayala Pharmaceuticals Inc financials
Revenue TTM | $1.7 million |
---|---|
Gross profit TTM | $1 million |
Return on assets TTM | -78.21% |
Return on equity TTM | -161.85% |
Profit margin | 0% |
Book value | $0.59 |
Market Capitalization | $7.9 million |
TTM: trailing 12 months
Ayala Pharmaceuticals Inc share dividends
We're not expecting Ayala Pharmaceuticals Inc to pay a dividend over the next 12 months.
Ayala Pharmaceuticals Inc share price volatility
Over the last 12 months, Ayala Pharmaceuticals Inc's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ayala Pharmaceuticals Inc's is 1.9895. This would suggest that Ayala Pharmaceuticals Inc's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Ayala Pharmaceuticals Inc overview
Ayala Pharmaceuticals, Inc. , a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinical trial for the treatment of recurrent/metastatic adenoid cystic carcinoma for patients bearing Notch-activating mutations. It is also involved in developing AL102, a potent, selective, and oral small molecule GSI that is in Phase II/III pivotal study for the treatment of desmoid tumors. Ayala Pharmaceuticals, Inc. has a collaboration agreement with Novartis International Pharmaceutical Limited to develop AL102 for the treatment of multiple myeloma. The company was incorporated in 2017 and is headquartered in Rehovot, Israel.
Frequently asked questions
nullWhat percentage of Ayala Pharmaceuticals Inc is owned by insiders or institutions?
Currently 29.741% of Ayala Pharmaceuticals Inc shares are held by insiders and 37.573% by institutions. How many people work for Ayala Pharmaceuticals Inc?
Latest data suggests 35 work at Ayala Pharmaceuticals Inc. When does the fiscal year end for Ayala Pharmaceuticals Inc?
Ayala Pharmaceuticals Inc's fiscal year ends in December. Where is Ayala Pharmaceuticals Inc based?
Ayala Pharmaceuticals Inc's address is: 4 Oppenheimer Street, Rehovot, Israel, 7670104 What is Ayala Pharmaceuticals Inc's ISIN number?
Ayala Pharmaceuticals Inc's international securities identification number is: US05465V1089 What is Ayala Pharmaceuticals Inc's CUSIP number?
Ayala Pharmaceuticals Inc's Committee on Uniform Securities Identification Procedures number is: 05465V108
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
eToro review 2024: Commission-free social trading and investing
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
-
Titan Review 2024: Wealth Management With a No-Advisory-Fee Robo-Advisor
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
-
Public.com Review 2024: No-Fee Options, With Rebates
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question